Equities

Simply Good Foods Co

Simply Good Foods Co

Actions
Consumer Staples Food Producers
  • Price (USD)34.63
  • Today's Change0.01 / 0.03%
  • Shares traded207.79k
  • 1 Year change-3.67%
  • Beta0.6685
Data delayed at least 15 minutes, as of Apr 26 2024 17:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Simply Good Foods Company is a consumer-packaged food and beverage company. The product portfolio the Company develops, markets, and sells consists primarily of protein bars, ready-to-drink (RTD) shakes, sweet and salty snacks, and confectionery products marketed under the Atkins, and Quest brand names. The Company's nutritious snacking platform consists of brands that specialize in providing products for consumers that follow certain nutritional philosophies and health-and-wellness trends. Atkins brand specializes in providing products for consumers following a low-carb lifestyle or seeking to lose weight, and Quest brand for consumers seeking a variety of protein-rich foods and beverages. Atkins brand products consist of protein bars, RTD shakes, confections, cookies, and chips. It distributes its products in retail channels, primarily in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, specialty, and other channels.

  • Revenue in USD (TTM)1.27bn
  • Net income in USD140.76m
  • Incorporated2017
  • Employees271.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Xenon Pharmaceuticals Inc0.00-182.39m3.02bn251.00--3.26-----2.73-2.730.0012.310.00----0.00-21.22-20.71-21.86-21.81-------683.58----0.00---100.00---45.99--61.77--
10X Genomics Inc618.73m-255.10m3.21bn1.26k--4.32--5.18-2.18-2.185.286.220.62062.705.65491,443.20-25.59-25.52-29.39-29.0566.1575.88-41.23-48.534.11--0.00--19.8133.43-53.67--49.15--
Iovance Biotherapeutics Inc1.19m-444.04m3.22bn557.00--5.06--2,710.85-1.89-1.890.00512.280.0017----2,134.65-61.49-51.47-71.47-57.56-804.54---37,345.42-137,873.802.70--0.0017-------12.16--79.44--
Fortrea Holdings Inc3.11bn-3.40m3.25bn18.00k--1.8634.931.04-0.0379-0.037935.0319.58------172,722.20--------16.74---0.1094----1.270.478--0.4167---101.76------
SpringWorks Therapeutics Inc5.45m-325.10m3.27bn305.00--5.19--600.96-5.14-5.140.08628.520.008----17,859.02-47.95-36.97-53.00-39.4992.25---5,968.50-2,176.466.37--0.00-------17.19--90.68--
Crinetics Pharmaceuticals Inc4.01m-214.53m3.30bn290.00--5.35--821.24-3.70-3.700.06917.910.0081--0.704813,837.93-42.39-42.53-45.71-45.36-----5,216.32-5,446.39----0.00---15.2810.57-30.88--34.65--
Axsome Therapeutics Inc270.60m-239.24m3.39bn545.00--17.73--12.52-5.20-5.205.964.030.58852.684.08496,513.80-52.02-64.55-69.92-82.2390.37---88.41-227.053.52-35.930.4825--440.80---27.84--77.86--
Biohaven Ltd0.00-408.17m3.40bn239.00--7.30-----5.67-5.670.005.280.00----0.00-69.48---79.29--------------0.00------28.43------
Immunitybio Inc622.00k-583.20m3.44bn628.00------5,536.81-1.13-1.130.0012-0.8750.0014--0.246990.45-134.71-112.76-377.77-316.07-----93,866.88-37,700.74---2.083.32--159.1767.62-40.00--18.48--
Simply Good Foods Co1.27bn140.76m3.46bn271.0024.862.1021.382.731.391.3912.5316.480.59776.918.564,671,908.006.653.666.953.8337.2638.9011.126.803.099.260.12610.006.3323.5623.0313.6547.09--
Ultragenyx Pharmaceutical Inc434.25m-606.64m3.61bn1.28k--13.11--8.31-8.33-8.335.913.350.2861.497.63340,320.50-39.96-33.35-48.63-38.3089.5993.13-139.70-154.712.49--0.00--19.5253.1814.25--62.91--
Alvotech SA93.38m-551.73m3.64bn999.00------39.00-2.40-2.400.4109-3.490.1052.201.3993,475.48-62.04---81.72---72.26---590.83--0.4614-1.297.52--9.84---7.43------
Insmed Inc305.21m-749.57m3.70bn912.00------12.13-5.35-5.352.17-2.240.20440.85628.61334,657.90-50.20-40.96-58.32-46.8878.5277.99-245.59-212.923.75-17.211.39--24.3998.78-55.66---2.15--
Data as of Apr 26 2024. Currency figures normalised to Simply Good Foods Co's reporting currency: US Dollar USD

Institutional shareholders

49.97%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 202313.06m13.08%
The Vanguard Group, Inc.as of 31 Dec 202310.66m10.68%
Capital Research & Management Co. (World Investors)as of 31 Dec 20236.16m6.17%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20233.41m3.42%
SSgA Funds Management, Inc.as of 31 Dec 20233.39m3.40%
Champlain Investment Partners LLCas of 31 Dec 20233.08m3.09%
Dimensional Fund Advisors LPas of 31 Dec 20232.89m2.90%
Silvercrest Asset Management Group LLCas of 31 Dec 20232.79m2.79%
Neuberger Berman Investment Advisers LLCas of 31 Dec 20232.42m2.43%
Fuller & Thaler Asset Management, Inc.as of 31 Dec 20232.01m2.02%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.